KTTA - Pasithea Therapeutics Corp
Previous close
4.7104
0 0%
Share volume: 942
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.71
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-16 | 2022-08-15 | 2022-11-14 | 2023-03-30 | 2023-05-12 | 2023-08-11 | 2023-11-13 | |
| Assets | ||||||||
| Total Assets | 51.079 M | 53.028 M | 49.608 M | 45.180 M | 42.045 M | 38.149 M | 30.657 M | |
| Current Assets | 50.950 M | 48.614 M | 44.469 M | 34.077 M | 31.113 M | 28.037 M | 20.771 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 628.740 K | 674.208 K | 2.071 M | 627.666 K | 1.099 M | 1.267 M | 1.092 M | |
| Short Term Investments | 628.740 K | 674.208 K | 2.071 M | 627.666 K | 1.099 M | 1.267 M | 1.092 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 302.132 K | 15.782 K | 122.500 K | 95.000 K | |
| Current Cash | 50.321 M | 47.940 M | 42.398 M | 33.147 M | 29.914 M | 26.648 M | 19.585 M | |
| Total Non-current Assets | 128.619 K | 4.413 M | 5.139 M | 11.103 M | 10.932 M | 10.112 M | 9.886 M | |
| Property Plant Equipment | 128.619 K | 169.559 K | 340.512 K | 378.783 K | 174.906 K | 173.298 K | 145.924 K | |
| Other Assets | 0.000 | 410.392 K | 931.964 K | 874.463 K | 460.539 K | 419.885 K | 378.453 K | |
| Intangible Assets | 0.000 | 0.000 | 12.502 K | 8.587 M | 8.414 M | 8.256 M | 8.099 M | |
| Goodwill | 0.000 | 3.833 M | 3.854 M | 1.263 M | 1.263 M | 1.263 M | 1.263 M | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 51.079 M | 53.028 M | 49.608 M | 45.180 M | 42.045 M | 38.149 M | 30.657 M | |
| Total liabilities | 1.101 M | 1.554 M | 2.819 M | 2.682 M | 2.910 M | 2.559 M | 2.284 M | |
| Total current liabilities | 433.684 K | 950.112 K | 1.514 M | 1.878 M | 2.122 M | 2.229 M | 2.044 M | |
| Accounts Payable | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 667.503 K | 245.803 K | 581.120 K | 140.611 K | 187.481 K | 74.055 K | 29.059 K | |
| Current long term debt | 0.000 | 101.418 K | 258.031 K | 263.291 K | 429.077 K | 303.011 K | 174.471 K | |
| Long term debt | 0.000 | 358.245 K | 724.386 K | 663.596 K | 300.480 K | 256.084 K | 210.817 K | |
| Other liabilities | 667.503 K | 245.803 K | 581.120 K | 140.611 K | 187.481 K | 74.055 K | 29.059 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 49.977 M | 51.474 M | 46.789 M | 42.498 M | 39.135 M | 35.590 M | 28.374 M | |
| Common stock | 23.008 M | 23.444 M | 26.549 M | 28.006 M | 26.073 M | 26.128 M | 25.161 M | |
| Retained earnings | -3.789 M | -6.447 M | -11.033 M | -19.357 M | -22.895 M | -26.658 M | -30.270 M |